Association between baseline tumor dimensions and survival in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Ahn, Daniel H.
Dahlberg, Suzanne Eleanor
Sandler, Alan
Perry, Michael C.
Schiller, Joan H.
Brahmer, Julie R.
Johnson, David H.
Gerber, David E.
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[4] Univ Missouri, Ellis Fischel Canc Ctr, Columbia, MO USA
[5] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8046
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association Between Baseline Tumor Diameters and Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Gerber, D. E.
    Dahlberg, S. E.
    Sandler, A. B.
    Perry, M. C.
    Schiller, J. H.
    Brahmer, J. R.
    Johnson, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S217 - S218
  • [2] Tumor regression as a continuous variable and survival in advanced non-small cell lung cancer (NSCLC).
    Stewart, David J.
    Lu, Charles
    Saintigny, Pierre
    Goss, Glenwood D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] The association between PTEN expression and survival in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with erlotinib
    Hensing, T. A.
    Fidler, M. J.
    Wong, F.
    Polish, A.
    Watkin, W.
    Basu, S.
    Kaiser-Walters, K. A.
    Pool, M.
    Coon, J.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
    Soussi, Ghassen
    Racil, Hajer
    Bacha, Saoussen
    Rouhou, Sana Cheikh
    Zidi, Asma
    Ayadi, Aida
    Chaouch, Nawel
    Chabbou, Abdellatif
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [5] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer
    Sun, Lova
    Bleiberg, Benjamin
    Hwang, Wei-Ting
    Marmarelis, Melina E.
    Langer, Corey J.
    Singh, Aditi
    Cohen, Roger B.
    Mamtani, Ronac
    Aggarwal, Charu
    JAMA ONCOLOGY, 2023, 9 (08) : 1075 - 1082
  • [7] Baseline tumour measurements predict survival in advanced non-small cell lung cancer
    Gerber, D. E.
    Dahlberg, S. E.
    Sandler, A. B.
    Ahn, D. H.
    Schiller, J. H.
    Brahmer, J. R.
    Johnson, D. H.
    BRITISH JOURNAL OF CANCER, 2013, 109 (06) : 1476 - 1481
  • [8] Baseline tumour measurements predict survival in advanced non-small cell lung cancer
    D E Gerber
    S E Dahlberg
    A B Sandler
    D H Ahn
    J H Schiller
    J R Brahmer
    D H Johnson
    British Journal of Cancer, 2013, 109 : 1476 - 1481
  • [9] ASSOCIATION BETWEEN TUMOR HETEROGENEITY AND OVERALL SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Song, Jiangdian
    Dong, Di
    Huang, Yanqi
    Liu, Zaiyi
    Tian, Jie
    2016 IEEE 13TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2016, : 1249 - 1252
  • [10] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
12345